These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7523036)

  • 21. [Cost analysis of ultrasound-guided transrectal needle biopsy in prostatic carcinoma].
    Bissoli E; Fandella A; La Torre E; Faggiano L; Anselmo G; Frasson F
    Radiol Med; 1998 Apr; 95(4):353-6. PubMed ID: 9676215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should helical CT scanning of the thoracic cavity replace the conventional chest x-ray as a primary assessment tool in pediatric trauma? An efficacy and cost analysis.
    Renton J; Kincaid S; Ehrlich PF
    J Pediatr Surg; 2003 May; 38(5):793-7. PubMed ID: 12720196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of patient follow-up after potentially curative lung cancer treatment.
    Virgo KS; Naunheim KS; McKirgan LW; Kissling ME; Lin JC; Johnson FE
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):356-63. PubMed ID: 8751503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine preoperative chest X-rays.
    Ainley-Walker JC
    Anaesthesia; 1979; 34(7):686. PubMed ID: 517733
    [No Abstract]   [Full Text] [Related]  

  • 25. [Screening for the early diagnosis of prostatic carcinoma in Ossola: results after 1 year of effort].
    Pagani G; Iannicelli P; Rosa A; Aimè G; Ceratti G; Cobianchi PG
    Arch Ital Urol Androl; 1994 Feb; 66(1):47-50. PubMed ID: 7516781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cost-Utility Analysis of Prostate Cancer Screening in Australia.
    Keller A; Gericke C; Whitty JA; Yaxley J; Kua B; Coughlin G; Gianduzzo T
    Appl Health Econ Health Policy; 2017 Feb; 15(1):95-111. PubMed ID: 27757918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
    Shteynshlyuger A; Andriole GL
    J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis.
    Tawfik A
    Ont Health Technol Assess Ser; 2015; 15(11):1-37. PubMed ID: 26366237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies.
    Roth JA; Gulati R; Gore JL; Cooperberg MR; Etzioni R
    JAMA Oncol; 2016 Jul; 2(7):890-8. PubMed ID: 27010943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The National Cancer Institute Multi-Screening Trial.
    Prorok P
    Can J Oncol; 1994 Nov; 4 Suppl 1():98-9; discussion 100-1. PubMed ID: 8853500
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening for prostate cancer. A decision analytic view.
    Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
    JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.
    Raj GV; Partin AW; Polascik TJ
    Cancer; 2002 Feb; 94(4):987-96. PubMed ID: 11920467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
    Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
    Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An audit of follow-up chest radiography after coronary artery bypass graft.
    Karthik S; O'Regan DJ
    Clin Radiol; 2006 Jul; 61(7):616-8. PubMed ID: 16784948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in treatment costs for localized prostate cancer: the healthy screenee effect.
    Zeliadt SB; Etzioni R; Ramsey SD; Penson DF; Potosky AL
    Med Care; 2007 Feb; 45(2):154-9. PubMed ID: 17224778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and screening for prostate cancer.
    Moul JW
    Am J Manag Care; 1997 Aug; 3(8):1200-5; quiz 1208, 1210. PubMed ID: 10170302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of chest roentgenograms.
    Geitung JT; Skjaerstad LM; Göthlin JH
    Eur Radiol; 1999; 9(4):721-3. PubMed ID: 10354893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for patients with newly diagnosed oral squamous cell carcinoma and a positive chest CT. A cohort study on the effects on treatment planning and incidence.
    Jaspers GW; Witjes MJ; Groen HJ; Groen H; Rödiger LA; Roodenburg JL
    Eur J Surg Oncol; 2011 Mar; 37(3):272-7. PubMed ID: 21232904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.